Vancomycin Hydrochloride Capsules — Class II drug recall D-0396-2015
Terminated recall by Actavis Inc, reported 2015-03-11, distributed nationwide. Subpotent Drug
| Recall number | D-0396-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Inc, Parsippany, NJ, United States |
| Recall initiated | 2015-02-12 |
| Classified | 2015-03-03 |
| Reported by FDA | 2015-03-11 |
| Terminated | 2015-12-04 |
| Distributed | Nationwide (US) |
| Quantity | 51,472 cartons |
| Reason classes | potency |
| NDC | 00591-3560-15 |
| Lot numbers | 310935, 3109552, 3110204, 3112972, 3114073, 3115756, 3115888, 3118059 |
| Expiration dates | 2015-03-31, 2015-07-31, 2015-08-31, 2015-10-31, 2015-11-30 |
Product
Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3560-15
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0396-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.